IP Library Granted Patent US 8,497,065
Granted Patent B2
US 8,497,065 · App. 12/371,515 · Granted Jul 30, 2013

Methods and kits for extraction of DNA

Inventors: Maxim G. Brevnov (Union City, CA); Hemant S. Pawar (Fort Worth, TX); Manohar R. Furtado (San Ramon, CA); Jaiprakash Shewale (Santa Clara, CA)
Assignee: Life Technologies Corporation
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,497,065
App. No.
12/371,515
Granted
Jul 30, 2013
Kind
B2
Abstract

Methods and materials are disclosed for use in recovering a biopolymer from a solution. In particular, the invention provides methods for extraction and isolation of nucleic acids from biological materials. The nucleic acids can be separated by forming a stable complex with soluble polysaccharide polymers and magnetic particles, in the presence of detergents and solvent. When the particles are magnetically separated out of the solution, the nucleic acids are separated with them. The nucleic acids can subsequently be released and separated from the particles. The nucleic acid preparation is useful for achieving efficient and accurate results in downstream molecular techniques such as quantification, identification of the source of the nucleic acids, and genotyping.

Claims (10)

1. A method comprising:

(a) contacting a composition comprising a nucleic acid with a polymer, a detergent, isopropanol and dextran encased particles thereby forming a blend, wherein the polymer is dextran and the detergent is lauroyl sarcosinate;

(b) isolating the dextran encased particles from the blend;

(c) and

(d) contacting the recovered dextran encased particles with a solution comprising ethanol and thereby isolating the nucleic acid from the composition.

2. The method of claim 1 , wherein the nucleic acid is derived from a sample of biological material comprising one or more of blood, blood stain, saliva, saliva stain, buccal cells, buccal swab, semen, or semen stain.

3. The method of claim 1 , wherein the dextran is in the range of 1-5 mg/ml.

4. The method of claim 1 , wherein the dextran has a molecular weight of 5,000,000 to 40,000,000.

5. The method of claim 1 , wherein the lauroyl sarconsinate is in the range of about 5-15%.

6. The method of claim 1 , wherein the dextran encased particles are in the range of about 2-10 mg/ml.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 14, 2014
From: BREVNOV, MAXIM; PAWAR, HEMANT; FURTADO, MANOHAR; SHEWALE, JAIPRAKASH
To: LIFE TECHNOLOGIES CORPORATION
Reel/Frame 033943/0677 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 4, 2009
From: BREVNOV, MAXIM G.; PAWAR, HEMANT S.; FURTADO, MANOHAR R.; SHEWALE, JAIPRAKASH G.
To: LIFE TECHNOLOGIES CORPORATION
Reel/Frame 022636/0073 →
Continuity (2)
Provisional Application 61028986 · Feb 15, 2008
Related Publication 20090209751A1 · Aug 20, 2009